These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31866505)

  • 1. Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: Role of surface engineered nanocarriers.
    Gopalan D; Pandey A; Udupa N; Mutalik S
    J Control Release; 2020 Mar; 319():183-200. PubMed ID: 31866505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release.
    Liu J; Cabral H; Mi P
    Adv Drug Deliv Rev; 2024 Apr; 207():115239. PubMed ID: 38437916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Smart Drug Delivery System and Its Clinical Potential.
    Liu D; Yang F; Xiong F; Gu N
    Theranostics; 2016; 6(9):1306-23. PubMed ID: 27375781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative review of nanotechnology-based therapeutics for kidney diseases.
    Cheng HT; Ngoc Ta YN; Hsia T; Chen Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1953. PubMed ID: 38500369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms.
    Sun Y; Davis E
    Nanomaterials (Basel); 2021 Mar; 11(3):. PubMed ID: 33809633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic Approaches of Internalization, Subcellular Trafficking, and Cytotoxicity of Nanoparticles for Targeting the Small Intestine.
    Madni A; Rehman S; Sultan H; Khan MM; Ahmad F; Raza MR; Rai N; Parveen F
    AAPS PharmSciTech; 2020 Nov; 22(1):3. PubMed ID: 33221968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage-Biomimetic Nanoplatform-Based Therapy for Inflammation-Associated Diseases.
    Qu Y; Chu B; Li J; Deng H; Niu T; Qian Z
    Small Methods; 2024 Jul; 8(7):e2301178. PubMed ID: 38037521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current knowledge of hybrid nanoplatforms composed of exosomes and organic/inorganic nanoparticles for disease treatment and cell/tissue imaging.
    Soltanmohammadi F; Gharehbaba AM; Zangi AR; Adibkia K; Javadzadeh Y
    Biomed Pharmacother; 2024 Sep; 178():117248. PubMed ID: 39098179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional cell membranes-based nano-carriers for targeted therapies: a review of recent trends and future perspective.
    Li M; Guo Q; Zhong C; Zhang Z
    Drug Deliv; 2023 Dec; 30(1):2288797. PubMed ID: 38069500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revolutionizing Stroke Care: Nanotechnology-Based Brain Delivery as a Novel Paradigm for Treatment and Diagnosis.
    Balaji PG; Bhimrao LS; Yadav AK
    Mol Neurobiol; 2024 Jun; ():. PubMed ID: 38829514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocomputing nanoplatforms as therapeutics and diagnostics.
    Evans AC; Thadani NN; Suh J
    J Control Release; 2016 Oct; 240():387-393. PubMed ID: 26826305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes against Alzheimer's Disease: Current Research and Future Prospects.
    Constantinou C; Meliou K; Skouras A; Siafaka P; Christodoulou P
    Biomedicines; 2024 Jul; 12(7):. PubMed ID: 39062092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research Progress and Prospect of Nanoplatforms for Treatment of Oral Cancer.
    Zhao Z; Li D; Wu Z; Wang Q; Ma Z; Zhang C
    Front Pharmacol; 2020; 11():616101. PubMed ID: 33391000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomimetic Nanocarriers for Cancer Target Therapy.
    Guido C; Maiorano G; Cortese B; D'Amone S; Palamà IE
    Bioengineering (Basel); 2020 Sep; 7(3):. PubMed ID: 32937963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomedical Application of Reactive Oxygen Species-Responsive Nanocarriers in Cancer, Inflammation, and Neurodegenerative Diseases.
    Liu J; Li Y; Chen S; Lin Y; Lai H; Chen B; Chen T
    Front Chem; 2020; 8():838. PubMed ID: 33062637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium Carbonate-Based Nanoplatforms for Cancer Therapeutics: Current State of Art and Future Breakthroughs.
    Zhou X; Wang Q; Lei Z; Zhang K; Zhen S; Yao H; Zu Y
    ACS Omega; 2024 Mar; 9(11):12539-12552. PubMed ID: 38524488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plant-Derived Vesicle-like Nanoparticles: The Next-Generation Drug Delivery Nanoplatforms.
    Wang X; Xin C; Zhou Y; Sun T
    Pharmaceutics; 2024 Apr; 16(5):. PubMed ID: 38794248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering exosomes for targeted drug delivery.
    Liang Y; Duan L; Lu J; Xia J
    Theranostics; 2021; 11(7):3183-3195. PubMed ID: 33537081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unlocking the Power of Exosomes for Crossing Biological Barriers in Drug Delivery.
    Elliott RO; He M
    Pharmaceutics; 2021 Jan; 13(1):. PubMed ID: 33477972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Trends of Targeted Drug Delivery for Oral Cancer Therapy.
    Zhang M; Liang J; Yang Y; Liang H; Jia H; Li D
    Front Bioeng Biotechnol; 2020; 8():618931. PubMed ID: 33425881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.